Gennex Laboratories Ltd

Gennex Laboratories Business Update

Subsidiary Deccan Remedies Ltd received approvals from the Drug Control Administration, Andhra Pradesh, to manufacture ten additional pharmaceutical products and test licences at its facility.

Gennex Laboratories Annual General Meeting

Gennex Laboratories Limited announced the closure of its register of members from September 23 to September 30, 2026. This is for the upcoming 41st Annual General Meeting.

Gennex Laboratories Board Meeting Outcome

Gennex Laboratories announced the outcome of its board meeting, approving the draft directors' report and scheduling the 41st Annual General Meeting for September 30, 2026.

Gennex Laboratories Board Meeting Date

Gennex Laboratories has announced a board meeting scheduled for September 4, 2026, to discuss the upcoming 41st Annual General Meeting and other business matters.

Gennex Laboratories Q1 FY27 Results: Net Profit ₹4.7 Cr, Down 6.0% YoY

Gennex Laboratories Ltd reported revenue from operations of ₹39.8 Cr (+16.4% YoY) and net profit of ₹4.7 Cr (-6.0% YoY) for Q1 FY27.

Key figure

Net profit ₹4.7 Cr · -6.0% YoY

Gennex Laboratories Board Meeting Date

Gennex Laboratories scheduled a board meeting for August 14, 2026. The board will review unaudited financial statements for the June 30, 2026 quarter.

Gennex Laboratories Other Announcement

Gennex Laboratories Ltd filed its quarterly shareholding pattern. The company has applied for trading approval for 1.55 crore shares issued via warrant conversion.